Intrinsic Value of S&P & Nasdaq Contact Us

Aileron Therapeutics, Inc. ALRN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
37/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Aileron Therapeutics, Inc. (ALRN) has 20 known insider and institutional holders on record. The largest holder is Satter Muneer A with 16,609,449 shares. Other notable holders include GELMAN GARY and Novartis Bioventures Ltd.

ALRN Insider Ownership

Top Holder
Satter Muneer A
16,609,449 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Satter Muneer A See Remarks 16,609,449 2021-01-08
100%
2 Gelman Gary 10 Percent Owner, Officer: Chairman, President & CEO 2,896,400 2012-01-04
17%
3 Novartis Bioventures Ltd 10 Percent Owner 2,100,004 2019-04-02
13%
4 University Of Texas/texas Am Investment Management Co 10 Percent Owner 1,751,256 2024-06-17
11%
5 Apple Tree Partners Ii Lp 10 Percent Owner 1,391,682 2018-06-26
8%
6 Wanstall Rick See Remarks 393,000 2022-03-30
2%
7 Annis Allen SVP, Research 313,000 2022-03-30
2%
8 Gregory Kathryn SVP, Chief Business Officer 185,000 2020-02-04
1%
9 Yanchik Joseph A., Iii See Remarks 157,449 2017-07-27
1%
10 Dougherty Donald SVP & Chief Financial Officer 150,000 2019-04-17
1%
11 Vukovic Vojo Chief Medical Officer 150,000 2022-03-30
1%
12 Kapnick Scott 10 Percent Owner 66,666 2018-08-14
0%
13 Morrison Jodie Pope Director 54,500 2022-06-17
0%
14 Bailey Jeffrey Allen Director 54,500 2022-06-17
0%
15 Mckee William Director 54,500 2022-06-17
0%
16 Sigal Nolan Howard Director 54,500 2022-06-17
0%
17 Nelson Kira See Remarks 36,844 2017-07-27
0%
18 Ambros Reinhard J. Director 35,000 2024-12-06
0%
19 Fairey William Director 35,000 2024-12-06
0%
20 Aivado Manuel Director 35,000 2024-12-06
0%

No ownership data available for ALRN.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message